US Patent 9023357 Anti-prolactin receptor antibody formulations
Patent 9023357 was granted and assigned to Bayer Healthcare on May, 2015 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9023357 Anti-prolactin receptor antibody formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
